CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Delisting notice
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 42 of 77 · 1,539 filings